Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease

Neurobiology of Aging

Volumn 18, Issue 5, 1997, Pages 457-461

  Lovell, M A ^a,b   Ehmann, W D ^a,b   Mattson, M P ^b   Markesbery, W R ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

4 Hydroxynonenal; Alzheimer's disease; Lipid peroxidation; Oxidative stress; Ventricular fluid

Indexed keywords

4 HYDROXYNONENAL; FATTY ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALDEHYDES; ALZHEIMER DISEASE; BODY FLUIDS; CEREBRAL VENTRICLES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE PROTEINASE INHIBITORS; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS;

EID: 0030714092     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00108-5     Document Type: Article

References (54)

1. Balazs L., Leon M. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19:1994;1131-1137.
2. Benedetti A., Casini A. F., Ferrali M., Comporti M. Effects of diffusible products of peroxidation of rat liver microsomal lipids. Biochem. J. 180:1979;303-312.
3. Benedetti A., Comporti M., Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta. 620:1980;281-296.
4. Benedetti A., Comporti M. Formation, reaction and toxicity of aldehydes produced in the course of lipid peroxidation in cellular membranes. Bioelectrochem. Bioenergetics. 18:1987;187-202.
5. Benzi G., Moretti A. Are oxygen free radicals involved in Alzheimer's disease? Neurobiol. Aging. 16:1995;661-674.
6. q/11 . J. Neurochem. 69:1997;570-580.
7. Busciglio J., Yankner B. A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 378:1995;776-779.
8. Butterfield D. A., Hensley K., Harris M., Mattson M. P., Carney J. M. β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion Implications to Alzheimer's disease . Biochem. Biophys. Res. Commun. 200:1994;710-715.
9. Comporti M. Biology of disease. Lipid peroxidation and cellular damage in toxic liver injury. Lab. Invest. 53:1985;599-623.
10. Comporti M. Three models of free radical-induced cell injury. Chem. Biol. Interact. 7:1989;333-349.
11. Coyle J. T., Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science. 262:1993;689-695.
12. Ehmann W. D., Markesbery W. R., Alauddin M., Hossain T. I. M., Brubaker E. H. Brain trace elements in Alzheimer's disease. Neurotoxicology. 7:1986;197-206.
13. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
14. Esterbauer H. Aldehydic products of lipid peroxidation. McBrien D. C. H., Slater T. F. Free radicals, lipid peroxidation and cancer. 1992;101-128 Academic Press, London.
15. Good P. F., Perl D. P., Bierer L. M., Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease A laser microprobe (LAMMA) study . Ann. Neurol. 31:1992;286-292.
16. Good P. F., Werner P., Hsu A., Olanow C. W., Perl D. P. Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
17. Harman D. Free radical theory of aging a hypothesis on pathogenesis of senile dementia of the Alzheimer's type . Age. 16:1993;23-30.
18. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., Butterfield D. A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide Relevance to Alzheimer's disease . Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
19. Hensley K., Hall N., Subramanian R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Lovell M., Markesbery W. R., Butterfield D. A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
20. Jürgens G., Lang J., Esterbauer H. Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim. Biophys. Acta. 875:1986;103-114.
21. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G., Mattson M. P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide Role of the lipid peroxidation product 4-hydroxynonenal . J. Neurochem. 69:1997;273-284.
22. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
23. Kruman I., Bruce-Keller A. J., Bredesen D. E., Waeg G., Mattson M. P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
24. Ledesma M. D., Bonay P., Colaco C., Avila J. Analyses of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269:1994;21614-21619.
25. Lovell M. A., Ehmann W. D., Butler S. M., Markesbery W. R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
26. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;263-275.
27. Mapetschnig, S. Reactions of amino acids with 4-hydroxy-2,3-trans-pentanal and therapy of Ehrlich ascites tumors with the amino acid abducts. Austria: University of Graz; 1981: Thesis.
28. Mark R. J., Lovell M. A., Markesbery W. R., Uchida R., Mattson M. P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-261.
29. Mark R. J., Pang Z., Geddes J. W., Uchida K., Mattson M. P. Amyloid β-peptide impairs glucose intake in hippocampal and cortical neurons Involvement of membrane lipid peroxidation . J. Neurosci. 17:1997;1046-1054.
30. Markesbery W. R. The oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-137.
31. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease . Neurology. 34:1984;939-944.
32. Mecocci P., MacGarvey U., Kaufman A. E., Koontz D., Shoffner J. M., Wallace D. C., Beal M. F. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34:1993;609-616.
33. Mecocci P., MacGarvey U., Beal M. F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
34. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
35. Montine T. J., Amarnath V., Martin M. E., Strittmatter W. J., Graham D. G. E-4 hydroxy-2-nonenal is cytotoxic and cross links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148:1996;89-94.
36. Montine K. S., Olson S. J., Amarnath V., Whetsell W. O., Graham D. G., Montine T. J. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150:1997;437-443.
37. Mortimer J. A., Hutton J. T. Epidemiology and etiology of Alzheimer's disease. Hutton J. T., Kenny A. D. Senile dementia of the Alzheimer type. 1985;177-196 Liss, New York.
38. Nitsch R. M., Blusztajn J. K., Pittas A. G., Slack B. E., Growdon J. H., Wurtman R. J. Evidence for a membrane defect in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA. 89:1992;1671-1675.
39. Olanow C. W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
40. Prasad M. R., Lovell M. A., Yatkin M., Dhillon H., Markesbery W. R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 1997.
41. Pryor W. A., Porter N. A. Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic. Biol. Med. 8:1990;541-543.
42. Rossi M. A., Fidale F., Garramone A., Esterbauer H., Dianzani M. U. Effect of 4-hydroxyalkenals on hepatic phosphatidylinositol-4,5-bisphosphate-phospholipase C. Biochem. Pharmacol. 39:1990;1715-1719.
43. Samudralwar D. L., Diprete C. C., Ni B. F., Ehmann W. D., Markesbery W. R. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130:1995;139-145.
44. Schauenstein E. Autoxidation of polyunsaturated esters in water Chemical structure and biologic activity of the products . J. Lipid Res. 8:1967;417-428.
45. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., Markesbery W. R. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
46. Smith M. A., Sayre L., Perry G. Is Alzheimer's a disease of oxidative stress? Alzheimer Dis. Rev. 1:1996;63-67.
47. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F., Kowall N. Oxidative damage in Alzheimer's. Nature. 382:1996;120-121.
48. Subbarao K. V., Richardson J. S., Ang L. C. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55:1990;342-345.
49. Svennerholm L., Gottfries C. G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62:1994;1039-1047.
50. Thompson C. M., Markesbery W. R., Ehmann W. D., Mao Y. -X., Vance D. E. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology. 9:1988;1-8.
51. Vitek M. P., Bhattacharya K., Glendening J. M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;4766-4770.
52. Volicer L., Crino P. B. Involvement of free radicals in dementia of the Alzheimer type A hypothesis . Neurobiol. Aging. 11:1990;567-571.
53. Yan S. D., Chen X., Schmidt A. -M., Brett J., Godman G., Zou Y. -S., Scott C. W., Caputo C., Frappier T., Smith M. A., Perry G., Yen S. -H., Stern D. Glycated tau protein in Alzheimer disease A mechanism for induction of oxidant stress . Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.
54. Yoshino K., Matsuura T., Sano M., Saito S. -I., Tomita I. Fluorometric liquid chromatographic determination of aliphatic aldehydes arising from lipid peroxides. Chem. Pharm. Bull. 34:1986;1694-1700.